Acne FAQs

Adult acne is the persistence (or new appearance) of inflammatory acne beyond the typical adolescent window. Hormonal context, follicular keratinisation patterns, surface oil composition, microbial balance within follicles, and the interaction of these layers with environment and lifestyle each contribute. Adult acne often follows a different distribution and timeline from teenage acne; the dermatology consultation maps the contributors that apply for the individual patient.

For Fitzpatrick III–VI baselines the additional clinical concern alongside the active acne is the risk of post-inflammatory hyperpigmentation (PIH) following each lesion. Calibrated acne management in Indian skin treats both layers — the active acne and the PIH propensity — as part of the same plan rather than as separate problems. Some treatment options that are routine on lighter phototypes are calibrated more conservatively here.

Mild and intermittent acne sometimes responds adequately to over-the-counter routines applied with consistency over several weeks. Persistent acne extending beyond several months, moderate-to-severe inflammatory acne, acne producing visible PIH or scarring, hormonal-pattern acne (often jawline-and-chin distribution with menstrual-cycle flaring), acne accompanied by other symptoms suggesting hormonal context, and any acne that has resisted appropriate over-the-counter regimens benefit from clinical assessment. The consultation maps the case to a calibrated pathway rather than continuing trial-and-error with over-the-counter products that may compound the inflammatory load if mismatched.

Yes, with calibrated work. The framework for darker phototypes calibrates active-acne treatment alongside PIH prevention so that one does not undermine the other. Aggressive procedural intensity that produces clearance on lighter phototypes can compound PIH on Indian skin if applied without calibration; the consultation runs phototype-aware parameter selection across every step.

A typical plan combines a calibrated topical regimen (selected from retinoid, benzoyl-peroxide-class, antibiotic, azelaic-acid family, and others), oral therapy where indicated for moderate-to-severe presentations, supportive procedural work in selected cases, and lifestyle and routine guidance. The mix is calibrated to the patient rather than offered as a fixed package. The acne-treatment page covers the booking pathway; the acne and acne scars hub covers the broader cluster.

Isotretinoin is the appropriate option for selected patients with moderate-to-severe nodulocystic or recalcitrant acne, calibrated under clinical supervision with standard monitoring. Suitability is patient-specific and the framework reserves isotretinoin for the indications where its leverage is clinically warranted. It is not a first-line option for mild acne and is not appropriate for every patient. The consultation discusses whether it fits the case.

Long-term oral antibiotic use for acne is generally avoided per current dermatology framework. Antibiotic stewardship calibrates oral antibiotic courses to defined windows alongside other modalities that allow the antibiotic phase to taper. The framework treats long-term antibiotic monotherapy as an outdated default rather than current practice.

Selected calibrated peels contribute as adjunctive components within a broader acne plan — particularly for surface-level acne management and for post-acne pigmentation alongside the primary regimen. The chemical peel science page covers the chemistry; the chemical peel treatment page covers the booking pathway. Peels are not the primary acne intervention; they are adjunctive in calibrated cases.

Facials performed across active inflammatory acne can compound the inflammatory load and worsen the picture. The framework typically settles active inflammation through the primary acne pathway before introducing facial work in the same zone. The acne-treatment page covers the primary pathway; medi-facial work follows once inflammation has settled.

Selected dietary patterns — high-glycaemic-load diets and dairy in some patients — can amplify acne in some individuals though the effect varies substantially across patients. Published evidence supports a meaningful but individually variable dietary contribution; what works as dietary modification for one patient may make minimal difference for another. The framework discusses dietary contributors honestly with each patient rather than asserting universal dietary causation or universal dietary innocence. It is part of the conversation rather than the entire conversation, and any dietary modification trial runs alongside (not as a replacement for) the calibrated topical and systemic pathway.

Most calibrated acne plans show meaningful response over eight to twelve weeks rather than within days; patients are counselled honestly about this timeline at the consultation. Initial weeks may include a transient settling phase as the regimen takes effect, sometimes with mild flaring before clearance trajectory emerges. Plans that imply rapid clearance typically deliver inflammatory rebound, surface dryness, or under-treatment of the underlying drivers because clearance pace is biologically constrained rather than primarily a function of treatment intensity. The framework prioritises sustainable response over short-term marketing-grade clearance claims and counsels patients to plan around this timeline rather than against it.

Acne biology continues to operate after any treatment course, and selected patients experience flares or recurrence over years driven by hormonal, lifestyle, or environmental factors. Calibrated maintenance after the active treatment phase reduces recurrence rate; complete prevention of any future acne is not the deliverable. The framework treats acne management as ongoing supportive work rather than as a one-time fix.

Selected acne pathways are appropriate during pregnancy and selected pathways are not. Specific oral therapy options including isotretinoin and selected oral antibiotics are not used in pregnancy. The framework calibrates pregnancy-safe acne plans through the consultation in coordination with obstetric care where appropriate. Patients planning pregnancy or pregnant patients should disclose this at the consultation so the calibration is correct from the start.

Yes. PIH from acne typically fades over months without intervention, and calibrated dermatology pathways accelerate the trajectory in many patients. The active acne is settled first; PIH-targeted work then sits alongside maintenance regimen. The post-acne redness guide covers redness specifically; pigmentation pathways cover the brown-mark pattern. The pigmentation FAQs page may also be useful.

Active inflammatory acne is settled first before scar-architecture work begins; operating across active acne risks compounding the inflammatory load and producing post-procedure complications. Once the active phase has been stable for an appropriate window, atrophic-scar-pattern guides on this site (pitted, boxcar, rolling, ice-pick) cover the calibrated scar-architecture pathway.

Selected LED-light protocols can serve as supportive layer alongside the primary acne pathway rather than as standalone treatment. Marketing of "LED cures acne" is not consistent with the underlying evidence; LED is adjunctive at most. The LED light therapy page covers the principles framework.

Hormonal-pattern acne (often jawline-and-chin-distributed, sometimes flaring with menstrual cycle) responds to the calibrated combination of hormonal-context pathways alongside topical and selected oral therapy. The framework considers selected hormonal-modulating oral options for suitable women. Patients with concurrent hormonal symptoms may benefit from coordinated assessment with their gynaecologist or endocrinologist.